Skip to content

The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study

The Heidelberg Engineering ANTERION Anterior Segment Cornea and IOL Precision and Agreement Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04130490
Enrollment
176
Registered
2019-10-17
Start date
2019-10-11
Completion date
2023-12-30
Last updated
2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Cornea Abnormality, Healthy Eye, IOL, Post-Keratorefractive Surgery

Brief summary

This is a prospective clinical study that will be conducted at one clinical site located in the United States to assess anterior segment parameters with the ANTERION

Interventions

DEVICEANTERION

3 repeat measurements performed with two of the ANTERION acquisition types and 3 repeat measurements performed with 2 acquisition types of the references devices

Sponsors

Heidelberg Engineering GmbH
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age 22 years or older 2. Able and willing to undergo the test procedures, sign informed consent, and follow instructions 3. Able to fixate 4. With the following eye pathology status for the individual eye population: * A. Eye with normal anterior segment and crystalline lens * B. Eye with a cataract of grade 1.5 or higher * C. Eye with abnormal corneal shape * D. Eye with status post-keratorefractive surgery * E. Eye without a crystalline lens

Exclusion criteria

1. Subjects which were enrolled in the B-2018-1 clinical study 2. Active infection or inflammation in the study eye 3. Insufficient tear film or corneal reflex 4. Physical inability to be properly positioned at the study devices or eye exam equipment 5. Rigid contact lens wear 2 weeks prior to imaging 6. Soft lenses worn within one hour prior to imaging 7. With the following eye pathology status for the individual eye population: * A. Eye meets eligibility criteria for eye populations B, C, D or E * B. Eye meets eligibility criteria for eye populations C,D or E * C. Eye meets eligibility criteria for eye populations D or E * E. Eye with abnormal corneal shape (except status post-keratorefractive surgery)

Design outcomes

Primary

MeasureTime frameDescription
Precision and Agreement 71 dayReproducibility, repeatability and agreement of Anterior Chamber Volume (mm\^3) of ANTERION and the reference device
Precision and Agreement 41 dayReproducibility, repeatability and agreement of Posterior Corneal Topography parameters (6mm zone) of ANTERION and the reference device
Precision and Agreement 51 dayReproducibility, repeatability and agreement of Cornea Thickness (µm) of ANTERION and the reference device
Precision and Agreement 11 dayReproducibility, repeatability and agreement of Anterior Corneal Topography parameters (3mm ring) of ANTERION and the reference device
Precision and Agreement 21 dayReproducibility, repeatability and agreement of Anterior Corneal Topography parameters (6mm zone) of ANTERION and the reference device
Precision and Agreement 31 dayReproducibility, repeatability and agreement of Posterior Corneal Topography parameters (3mm ring) of ANTERION and the reference device
Precision and Agreement 61 dayReproducibility, repeatability and agreement of Lens Thickness, ACD, Pupil Diameter, White-to-White, Axial Length (mm) of ANTERION and the reference device

Secondary

MeasureTime frameDescription
Adverse Events Rate1 dayAdverse events found during the clinical study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026